Pharmacy

"Reduced drug development timelines, smaller batch sizes, increased safety requirements and more stringent validation guidelines are all driving the demand for single-use solutions in drug production," said Ken Frank, Senior Vice President, Pall Corporation & President, Pall's Biopharmaceutical Division.

Pall Corporation, a global leader in filtration, separation   and purification, introduces the Pall Allegro™ 200L single-use mixer for high-performance mixing in biopharmaceutical applications from pilot scale to full production. This is designed to provide exceptional mixing performance for a wide range of liquid-liquid and solid-liquid mixing applications,, including compounding, formulation, buffer and media preparation, and pH/conductivity adjustment.